UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 57

Sortiert nach

Immune Checkpoint Inhibitors: New Insights and Current Place in Cancer Therapy

Pharmacotherapy, 2015-10, Vol.35 (10), p.963-976

2015

Volltextzugriff (PDF)

Modeling antibody drug conjugate potential using a granzyme B antibody fusion protein

BMC biology, 2024-03, Vol.22 (1), p.66-66, Article 66

2024

Volltextzugriff (PDF)

Pathogenetic Features and Current Management of Glioblastoma

Cancers, 2021-02, Vol.13 (4), p.856

2021

Volltextzugriff (PDF)

Disrupting cancer angiogenesis and immune checkpoint networks for improved tumor immunity

Seminars in cancer biology, 2022-11, Vol.86 (Pt 3), p.981-996

2022

Volltextzugriff (PDF)

Dendritic cell vaccine therapy for colorectal cancer

Pharmacological research, 2021-02, Vol.164, p.105374-105374, Article 105374

2021

Volltextzugriff (PDF)

Targeting the pericyte antigen DLK1 with an alpha type-1 polarized dendritic cell vaccine results in tumor vascular modulation and protection against colon cancer progression

Frontiers in immunology, 2023-10, Vol.14, p.1241949-1241949

2023

Volltextzugriff (PDF)

Expression and characterization of soluble epitope-defined major histocompatibility complex (MHC) from stable eukaryotic cell lines

Journal of immunological methods, 2019-01, Vol.464, p.22-30

2019

Volltextzugriff (PDF)

Listeria-based vaccination against the pericyte antigen RGS5 elicits anti-vascular effects and colon cancer protection

Oncoimmunology, 2023-12, Vol.12 (1), p.2260620-2260620

2023

Volltextzugriff (PDF)

Chronic inflammation and immunologic-based constraints in malignant disease

Immunotherapy, 2011-10, Vol.3 (10), p.1265-1274

2011

Volltextzugriff (PDF)

Therapeutic Anti-Tumor Efficacy of DC-Based Vaccines Targeting TME-Associated Antigens Is Improved When Combined with a Chemokine-Modulating Regimen and/or Anti-PD-L1

Vaccines (Basel), 2024-07, Vol.12 (7), p.777

2024

Volltextzugriff (PDF)

Combined vaccine+axitinib therapy yields superior antitumor efficacy in a murine melanoma model

Melanoma research, 2012-06, Vol.22 (3), p.236-243

2012

Volltextzugriff (PDF)

Vaccines targeting tumor blood vessel antigens promote CD8(+) T cell-dependent tumor eradication or dormancy in HLA-A2 transgenic mice

The Journal of immunology (1950), 2012-02, Vol.188 (4), p.1782-1788

2012

Volltextzugriff (PDF)

Dendritic cell vaccines targeting tumor blood vessel antigens in combination with dasatinib induce therapeutic immune responses in patients with checkpoint-refractory advanced melanoma

Journal for immunotherapy of cancer, 2021-11, Vol.9 (11), p.e003675

2021

Volltextzugriff (PDF)

TCR-like antibody drug conjugates mediate killing of tumor cells with low peptide/HLA targets

mAbs, 2017-05, Vol.9 (4), p.603-614

2017

Volltextzugriff (PDF)

Dasatinib promotes the expansion of a therapeutically superior T-cell repertoire in response to dendritic cell vaccination against melanoma

Oncoimmunology, 2014-02, Vol.3 (2), p.e27589-e27589

2014

Volltextzugriff (PDF)

Intratumoral IL-12 Gene Therapy Results in the Crosspriming of Tc1 Cells Reactive Against Tumor-associated Stromal Antigens

Molecular therapy, 2011-04, Vol.19 (4), p.805-814

2011

Volltextzugriff (PDF)

Multi-parametric flow cytometry staining procedure for analyzing tumor-infiltrating immune cells following oncolytic herpes simplex virus immunotherapy in intracranial glioblastoma

Journal of biological methods, 2019-04, Vol.6 (2), p.e112

2019

Volltextzugriff (PDF)

Combined Tbet and IL12 Gene Therapy Elicits and Recruits Superior Antitumor Immunity In Vivo

Molecular therapy, 2012-03, Vol.20 (3), p.644-651

2012

Volltextzugriff (PDF)

Shock block for improved immunotherapy

Oncoimmunology, 2012-11, Vol.1 (8), p.1427-1429

2012

Volltextzugriff (PDF)

CD4+ T Lymphocytes Are Critical Mediators of Tumor Immunity to Simian Virus 40 Large Tumor Antigen Induced by Vaccination with Plasmid DNA

Journal of Virology, 2011-07, Vol.85 (14), p.7216-7224

2011

Volltextzugriff (PDF)

Role of the Innate Immune Response and Tumor Immunity Associated with Simian Virus 40 Large Tumor Antigen

Journal of Virology, 2010-10, Vol.84 (19), p.10121-10130

2010

Volltextzugriff (PDF)

Detection of human leukocyte antigen biomarkers in breast cancer utilizing label-free biosensor technology

Journal of visualized experiments, 2015-03 (97)

2015

Volltextzugriff (PDF)

Vaccines and Immunotherapeutics for the Treatment of Malignant Disease

Clinical & developmental immunology, 2010-01, Vol.2010 (1), p.697158-697158

2010

Volltextzugriff (PDF)

Tumor Immunity against a Simian Virus 40 Oncoprotein Requires CD8+ T Lymphocytes in the Effector Immune Phase

Journal of Virology, 2010-01, Vol.84 (2), p.883-893

2010

Volltextzugriff (PDF)

DNA vaccines: Successes and limitations in cancer and infectious disease

Journal of cellular biochemistry, 2006-05, Vol.98 (2), p.235-242

2006

Volltextzugriff (PDF)

1 – 25 von 57

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(53)
Mit Volltextzugriff
(55)

Publikationsform

Artikel
(55)
Buchkapitel
(2)

Sprache

Englisch
(57)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

Science & Technology
(38)
Life Sciences & Biomedicine
(33)
Animals
(21)
Mice
(17)
Immunology
(15)
Immunotherapy
(15)
Humans
(13)
Cancer
(12)
Oncology
(11)
Tumors
(10)
Cell Line, Tumor
(9)
Female
(9)
Lymphocytes
(8)
Mice, Inbred Balb C
(8)
Cd8-Positive T-Lymphocytes - Immunology
(7)
Dendritic Cells
(7)
Antigens
(6)
Flow Cytometry
(6)
Melanoma
(6)
Peptides
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Immune Checkpoint Inhibitors: New Insights and Current Place in Cancer Therapy

Modeling antibody drug conjugate potential using a granzyme B antibody fusion protein

Pathogenetic Features and Current Management of Glioblastoma

Disrupting cancer angiogenesis and immune checkpoint networks for improved tumor immunity

Dendritic cell vaccine therapy for colorectal cancer

Targeting the pericyte antigen DLK1 with an alpha type-1 polarized dendritic cell vaccine results in tumor vascular modulation and protection against colon cancer progression

Expression and characterization of soluble epitope-defined major histocompatibility complex (MHC) from stable eukaryotic cell lines

Listeria-based vaccination against the pericyte antigen RGS5 elicits anti-vascular effects and colon cancer protection

Chronic inflammation and immunologic-based constraints in malignant disease

Therapeutic Anti-Tumor Efficacy of DC-Based Vaccines Targeting TME-Associated Antigens Is Improved When Combined with a Chemokine-Modulating Regimen and/or Anti-PD-L1

Combined vaccine+axitinib therapy yields superior antitumor efficacy in a murine melanoma model

Vaccines targeting tumor blood vessel antigens promote CD8(+) T cell-dependent tumor eradication or dormancy in HLA-A2 transgenic mice

Dendritic cell vaccines targeting tumor blood vessel antigens in combination with dasatinib induce therapeutic immune responses in patients with checkpoint-refractory advanced melanoma

TCR-like antibody drug conjugates mediate killing of tumor cells with low peptide/HLA targets

Dasatinib promotes the expansion of a therapeutically superior T-cell repertoire in response to dendritic cell vaccination against melanoma

Intratumoral IL-12 Gene Therapy Results in the Crosspriming of Tc1 Cells Reactive Against Tumor-associated Stromal Antigens

Multi-parametric flow cytometry staining procedure for analyzing tumor-infiltrating immune cells following oncolytic herpes simplex virus immunotherapy in intracranial glioblastoma

Combined Tbet and IL12 Gene Therapy Elicits and Recruits Superior Antitumor Immunity In Vivo

Shock block for improved immunotherapy

CD4+ T Lymphocytes Are Critical Mediators of Tumor Immunity to Simian Virus 40 Large Tumor Antigen Induced by Vaccination with Plasmid DNA

Role of the Innate Immune Response and Tumor Immunity Associated with Simian Virus 40 Large Tumor Antigen

Detection of human leukocyte antigen biomarkers in breast cancer utilizing label-free biosensor technology

Vaccines and Immunotherapeutics for the Treatment of Malignant Disease

Tumor Immunity against a Simian Virus 40 Oncoprotein Requires CD8+ T Lymphocytes in the Effector Immune Phase

DNA vaccines: Successes and limitations in cancer and infectious disease

Suchergebnisse filtern